Somatic variants of eIF6 were recently identified in the hematopoietic cells of SDS patients and these variants were categorized as beneficial mutations that rescue the translational defect of SDS cells either by decreasing eIF6 levels or by disrupting the interactions between eIF6 and 60S (32,33). This evidence concerns the gene EIF6 and Shwachman-Diamond syndrome.